◆英語タイトル:Yale School of Medicine - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011924
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月13日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Yale School of Medicine (YSM), a subsidiary of Yale University is an educational service provider that offers bio-medical research, education and advanced health care. The center provides degree programs such as public health program, physician associate program, other PhD programs, medical degree program, nursing program, and others. It provides joint degrees with other Yale professional schools. The center offers research studies in the areas of epidemiology and public health, cell biology, biomedical engineering, comparative medicine, genetics, cellular and molecular physiology, and among others. It also provides patient care and clinical trial services. YSM is headquartered in New Haven, Connecticut, the US.
Yale School of Medicine – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Yale School of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Yale School of Medicine, Medical Devices Deals, 2011 to YTD 2017 9
Yale School of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Yale School of Medicine, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Pierre Fabre Pharma Enters into Partnership with Yale School of Medicine 11
Organovo Enters into Co-Development Agreement with Yale School of Medicine 12
Gilead Sciences Enters Into Research Collaboration With Yale School of Medicine 13
Licensing Agreements 14
NextCure Enters into Licensing Agreement with Yale School of Medicine 14
Yale School of Medicine – Key Competitors 15
Yale School of Medicine – Key Employees 16
Yale School of Medicine – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Government and Public Interest 19
Oct 11, 2017: Forray study reveals potential new treatment for postpartum smokers 19
Jul 13, 2017: Heart Study Finds Faulty Link Between Biomarkers And Clinical Outcomes 20
Feb 14, 2017: Study points to potential new brain cancer treatment 21
Apr 15, 2016: Yale researchers discover drug target in rare, lethal glandular cancer 22
Product News 23
Sep 20, 2016: Two mood drugs combat virus implicated in birth defects 23
Other Significant Developments 24
Oct 17, 2017: Yale launches new program in addiction medicine 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25
List of Tables
Yale School of Medicine, Pharmaceuticals & Healthcare, Key Facts 2
Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Yale School of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Yale School of Medicine, Deals By Therapy Area, 2011 to YTD 2017 8
Yale School of Medicine, Medical Devices Deals, 2011 to YTD 2017 9
Yale School of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Pierre Fabre Pharma Enters into Partnership with Yale School of Medicine 11
Organovo Enters into Co-Development Agreement with Yale School of Medicine 12
Gilead Sciences Enters Into Research Collaboration With Yale School of Medicine 13
NextCure Enters into Licensing Agreement with Yale School of Medicine 14
Yale School of Medicine, Key Competitors 15
Yale School of Medicine, Key Employees 16
Yale School of Medicine, Subsidiaries 18